Patients with breast cancer carrying the TP53 mutation were diagnosed with a higher glucose-6-phosphate isomerase (GPI) gene expression that indicates higher level of glycolysis in tumor cells and correlates with the degree of tumor malignancy (57). This evidence concerns the gene GPI and breast cancer.